ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Strides’ subsidiary inks pact with SUDA Pharmaceuticals for migraine drug
November 10, 2018Under the terms of agreement, SUDA will receive an upfront cash payment of $ 0.4 million and a further payment of $ 0.6 million on reaching certain milestones including the pilot first-in-man clinical study, submission and approval of the product in the U -
Strides’ subsidiary inks pact with SUDA Pharmaceuticals for migraine drug
November 10, 2018Under the terms of agreement, SUDA will receive an upfront cash payment of $ 0.4 million and a further payment of $ 0.6 million on reaching certain milestones including the pilot first-in-man clinical study, submission and approval of the product in the U
Pharma Sources Insight January 2025
